BAJAJ BROKING

Notification
No new Notification messages
Dhanlaxmi Crop Science IPO is Open!
Apply for the Dhanlaxmi Crop Science IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Syngene International Block Deal: Biocon to Sell 2% Stake at ₹825 per Share

Listen to our Podcast: Grow your wealth and keep it secure.

0:00 / 0:00

Synopsis:

Biocon is set to sell a 2% stake in Syngene International Ltd at ₹825 per share via a block deal, raising ₹660 crore. This sale represents a 0-4.9% discount on the current market price of ₹867.90.

Syngene International Ltd news today

Biocon Ltd plans to offload a 2% stake in Syngene International Ltd via a block deal at ₹825 per share. This indicative price is set at a discount of 0-4.9% to the current market price of ₹867.90, with the total transaction size estimated at ₹660 crore. The sale includes a 60-day lock-in period as per the deal's terms.

Also read: Metropolis Healthcare Acquires Core Diagnostics for ₹246

SYNGENE INTERNATIONAL LTD

Trade

881.0513.14 (1.51 %)

Updated - 10 December 2024
898.00day high
DAY HIGH
858.30day low
DAY LOW
4019608
VOLUME (BSE)

Key Takeaways

  • Stake Sale Size: 2% stake in Syngene International Ltd.

  • Deal Price: ₹825 per share.

  • Discount Range: 0-4.9% to current market price.

  • Transaction Value: ₹660 crore.

  • Lock-In Period: 60 days.

Also read: Vodafone Idea to Issue Shares Worth ₹1,980 Crore at 39% Premium

Financial Performance Of Syngene International Ltd

Quarterly And Half-Yearly Highlights

Metric

Q2 FY2025

Q2 FY2024

Half-Year FY2025

Half-Year FY2024

Revenue

₹891 crore

₹910 crore

₹1,680.7 crore

₹1,711.2 crore

Net Profit

₹106.1 crore

₹116.5 crore

-

-

Expenses

₹770.2 crore

₹773.6 crore

-

-

Cost of Chemicals

₹230.8 crore

₹241.8 crore

-

-

Employee Benefits Expense

₹251.5 crore

₹225.5 crore

-

-

The company reported a revenue decline of 2.1% year-on-year, while net profit dropped by 8.9% for Q2 FY2025. Employee costs rose to ₹251.5 crore compared to ₹225.5 crore in the same quarter last year.

Impact On Syngene International Ltd Share Price

Following the block deal announcement, Syngene International Ltd share price fell by 5.11%, closing at ₹872.70 on the BSE. The deal's pricing at a discount could further influence the share price in the near term, depending on market sentiment.

Biocon’s decision to divest a 2% stake in Syngene International Ltd aims to unlock significant capital while providing liquidity for strategic purposes. The development has drawn attention to Syngene’s financial performance and market response.

Also read: Tata Motors To Increase Passenger Vehicle Prices By Up To 3% From January

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here: https://bit.ly/3Tcsfuc

Share this article: 

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text